PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31634532-1	2020	BACKGROUND: Farnesoid X receptor (FXR) agonist, obeticholic acid (OCA), increases total and low-density lipoprotein cholesterol (LDL-C) in patients with nonalcoholic steatohepatitis (NASH).	obeticholic acid	48-64	xenotropic and polytropic retrovirus receptor 1	Homo sapiens	22-32	
31634532-1	2020	BACKGROUND: Farnesoid X receptor (FXR) agonist, obeticholic acid (OCA), increases total and low-density lipoprotein cholesterol (LDL-C) in patients with nonalcoholic steatohepatitis (NASH).	obeticholic acid	66-69	xenotropic and polytropic retrovirus receptor 1	Homo sapiens	22-32	
31634532-12	2020	Recently, obeticholic acid (OCA), a farnesoid X receptor agonist, improved liver disease but led to an increase in cholesterol, however, the impact of OCA on cholesterol is not well understood.	obeticholic acid	10-26	xenotropic and polytropic retrovirus receptor 1	Homo sapiens	46-56	
31634532-12	2020	Recently, obeticholic acid (OCA), a farnesoid X receptor agonist, improved liver disease but led to an increase in cholesterol, however, the impact of OCA on cholesterol is not well understood.	obeticholic acid	28-31	xenotropic and polytropic retrovirus receptor 1	Homo sapiens	46-56